Despite emerging conceptual models, e.g., to explain TEL-to-ALT switching in epithelial tissues (12), it remains largely unclear as to why TEL and/or ALT become activated in specific cancer subsets and what is the molecular mechanism (19). This evidence concerns the gene ETV6 and cancer.